MAM
Marks & Spencer India appoints Manish Kapoor as new managing director
MUMBAI: Marks & Spencer India has appointed Manish Kapoor as its new managing director, the company announced on 25 February.
Kapoor joins M&S from Pepe Jeans London, where he has served as managing director and CEO since January 2022. His appointment is expected to strengthen the British retailer’s market presence in India and drive sustainable growth.
With nearly two decades of experience in the retail and fashion industry, Kapoor brings extensive expertise in business expansion and digital innovation to his new role. His experience aligns with M&S’s international strategy focused on customer engagement and operational efficiency.
Prior to his leadership at Pepe Jeans, Kapoor held several senior positions within the company, including chief executive officer (2019-2021), chief business officer (2019), and sales director (2017-2019), where he managed 200 stores, over 170 shop-in-shops and more than 800 sales points.
His previous experience includes serving as COO for French Connection at Brand Marketing India and various leadership roles at Benetton Group, where he was responsible for operations across Southeast Asia and Australia. Earlier in his career, Kapoor worked as retail manager at Madura Garments and briefly as store merchandiser at Pantaloon Retail India Ltd.
The appointment comes as Marks and Spencer continues to strengthen its presence in the Indian market, with Kapoor expected to play a pivotal role in the retailer’s expansion strategy.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
